Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4713 results found.

Example of search result explained

Idacio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Fresenius Kabi Canada Ltd. (Fresenius)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114265

Idacio (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Fresenius Kabi Canada Ltd. (Fresenius)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114267

Hyrimoz (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,2 mL) DIN : 99114304
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114305
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114307
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114107
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114108

Hadlima PushTouch (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114232
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114230

Hadlima (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114231
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114229

Hyrimoz (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114306
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114308
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114109

Simlandi (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114145
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114147

Simlandi (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114150

Yuflyma (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114223
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114222

Yuflyma (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (uveitis)
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114224
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114221
Page 14 of 472

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.